» Articles » PMID: 6826252

Effects of Several Species of Human Leukocyte Interferon on Cytotoxic Activity of NK Cells and Monocytes

Overview
Journal Int J Cancer
Specialty Oncology
Date 1983 Mar 15
PMID 6826252
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Ten species of purified human leukocyte interferon were tested for their ability to modulate the cytolytic activity of natural killer (NK) cells and the cytolytic and cytostatic activities of monocytes. The interferon species were tested at several antiviral titers and examined for quantitative differences in their ability to modulate immunological function. At the higher doses of interferon (i.e., greater than 500 units) all of the interferon species demonstrated significant augmentation of cytolysis and cytostasis. However, when low levels (i.e., 10-50 units) of interferon were employed, appreciable differences between the various interferon species were seen. A similar pattern of relative potency among the various species of pure leukocyte interferon was seen for augmentation of cytolysis by monocytes and NK cells. In contrast, a different pattern of relative potency was observed for augmentation of cytostasis. These results demonstrated substantial quantitative differences (as much as 100-fold) in the ability of the various species of human leukocyte interferon to induce significant levels of augmentation of these cell-mediated functions. Such results should have significant impact in choosing a specific interferon species for appropriate clinical trials.

Citing Articles

Effects of Acute and Chronic Exercise on Immunological Parameters in the Elderly Aged: Can Physical Activity Counteract the Effects of Aging?.

Sellami M, Gasmi M, Denham J, Hayes L, Stratton D, Padulo J Front Immunol. 2018; 9:2187.

PMID: 30364079 PMC: 6191490. DOI: 10.3389/fimmu.2018.02187.


Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Machmach K, Leal M, Gras C, Viciana P, Genebat M, Franco E J Virol. 2012; 86(8):4245-52.

PMID: 22318133 PMC: 3318617. DOI: 10.1128/JVI.07114-11.


Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid.

Krause C, Izotova L, Ren G, Yuan Z, Shi Y, Chen C Stem Cell Res Ther. 2011; 2(2):15.

PMID: 21401924 PMC: 3226286. DOI: 10.1186/scrt56.


Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.

Katamura Y, Aikata H, Takaki S, Azakami T, Kawaoka T, Waki K J Gastroenterol. 2009; 44(5):492-502.

PMID: 19330281 DOI: 10.1007/s00535-009-0033-y.


Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.

Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T Br J Cancer. 2005; 93(5):557-64.

PMID: 16106266 PMC: 2361594. DOI: 10.1038/sj.bjc.6602742.